Middle East, North Africa, Afghanistan & Pakistan vs Netherlands: Antiretroviral therapy coverage

Middle East, North Africa, Afghanistan & Pakistan
28.7%
in 2024
Netherlands
89.0%
in 2023
Middle East, North Africa, Afghanistan & Pakistan rank
21st
Netherlands rank
21st

Antiretroviral therapy coverage over time

  • Middle East, North Africa, Afghanistan & Pakistan
  • Netherlands
020406080200020122024

How they compare

Netherlands currently reports 89.0% against 28.7% in Middle East, North Africa, Afghanistan & Pakistan, a difference of 60.3%.

That makes Netherlands's figure about 3.1 times Middle East, North Africa, Afghanistan & Pakistan's.

Across all 24 years both countries report, Netherlands has been ahead every year.

Middle East, North Africa, Afghanistan & Pakistan ranks 21st and Netherlands ranks 21st of 23 groups.

Netherlands has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Middle East, North Africa, Afghanistan & Pakistan Netherlands Difference Ahead
2000s 5.8% 53.5% 47.7% Netherlands
2010s 14.6% 77.2% 62.6% Netherlands
2020s 24.5% 87.8% 63.3% Netherlands

Averages of every year both report within each decade.

Frequently asked questions

Which has higher antiretroviral therapy coverage, Middle East, North Africa, Afghanistan & Pakistan or Netherlands?
Netherlands, at 89.0% against 28.7% in Middle East, North Africa, Afghanistan & Pakistan as of 2023.
What is the difference in antiretroviral therapy coverage between Middle East, North Africa, Afghanistan & Pakistan and Netherlands?
60.3%, with Netherlands ahead.
How many years of comparable data are there for Middle East, North Africa, Afghanistan & Pakistan and Netherlands?
24 years are reported by both, from 2000 to 2023.
How do Middle East, North Africa, Afghanistan & Pakistan and Netherlands rank globally for antiretroviral therapy coverage?
Middle East, North Africa, Afghanistan & Pakistan ranks 21st and Netherlands ranks 21st of 23 groups.
Where does this data come from?
UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage (% of people living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Middle East, North Africa, Afghanistan & Pakistan vs Netherlands: Antiretroviral therapy coverage. Statizoid, drawing on UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Retrieved 19 September 2026, from https://health.statizoid.com/compare/antiretroviral-therapy-coverage-percent-of-people-living-with-hiv/middle-east-north-africa-afghanistan-and-pakistan/netherlands/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/antiretroviral-therapy-coverage-percent-of-people-living-with-hiv/middle-east-north-africa-afghanistan-and-pakistan/netherlands/">Middle East, North Africa, Afghanistan & Pakistan vs Netherlands: Antiretroviral therapy coverage</a> — Statizoid

About this data

Indicator
Antiretroviral therapy coverage (% of people living with HIV)
Unit
% of people living with HIV
Source
UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
166 places, 4,061 data points, 2000–2024
Last refreshed

Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.